294 Prognostic impact of urokinase-type plasminogen activator system components in patients with clear cell renal cell carcinoma
✍ Scribed by Füssel, S.; Kotzsch, M.; Erdmann, K.; Taubert, H.; Lohse-Fischer, A.; Zastrow, S.; Meinhardt, M.; Bluemke, K.; Fornara, P.; Magdolen, V.; Wirth, M.P.
- Book ID
- 122203653
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 111 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1569-9056
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Urokinase-type plasminogen activator (upa) plays an important role in the destruction of the extracellular matrix and basement membrane around cancer cells. in the current study, the authors investigated upa expression in cancer cells and stromal cells in patients with gastric carcin
## BACKGROUND. Urokinase plasminogen activator (u-PA) plays a key role in the metastatic process by promoting plasmin mediated tissue degradation. Metastatic cell invasion requires localized proteolysis, which may be directed by u-PA receptor. The binding of u-PA and PAI-1 to the u-PA-receptor may